Cited by 15PARP inhibition in cancer therapyCancer survivorship and careOvarian cancer diagnosis and treatment

Lived experiences of women reporting fatigue during PARP inhibitor maintenance treatment for advanced ovarian cancer: a qualitative study

Poort, Hanneke, Fenton, Anny T.H.R., Thompson, Embree, Dinardo, Margaret M., Liu, Joyce F., Arch, Joanna J., Wright, Alexi A.·2021·Gynecologic Oncology

Abstract

Objective Oral PARP inhibitors (PARPi) have dramatically changed the treatment landscape for patients with advanced ovarian cancer. However, a subset of patients discontinue PARPi due to treatment-related fatigue. The current study sought to explore patients' lived experiences with fatigue on PARPi.Methods We conducted individual semi-structured interviews with N = 23 women receiving PARPi for advanced ovarian cancer who reported moderate to severe fatigue. Audiotaped interviews were transcribed and we used thematic analysis to code transcripts for emergent themes.Results Four overarching themes emerged. First, participants described their fatigue as milder than what they experienced on intravenous chemotherapy, but noted it consistently limited their daily activities, including work, and interfered with participation in family and social events. Second, fatigue negatively impacted participants' sense of self and identity. Third, most wanted to continue treatment and believed discontinuing PARPi would lead to a cancer recurrence or death. Finally, many participants reported that their support networks were unaware of their ongoing cancer treatment or the resulting fatigue; a situation that may prove isolating and result in reduced social support.Conclusions Our findings underscore patients' persistent experience of fatigue on PARPi, the impact of fatigue on multiple domains of functioning, and a lack of understanding of side effects resulting from oral maintenance treatments among patients' social networks. Our findings highlight the need for interventions to address treatment-related fatigue to limit the negative impacts of fatigue on ovarian cancer patients' well-being.

Integrity signals

Registry

Crossref · 10.1016/j.ygyno.2020.10.034

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Poort, H., Fenton, A. T. H. R., Thompson, E., Dinardo, M. M., Liu, J. F., Arch, J. J., & Wright, A. A.
Affiliations
  • Dana-Farber Cancer Institute (US)
  • University of Colorado Boulder (US)
Corresponding author
Poort, Hanneke
Venue
Gynecologic Oncology
Publisher
Elsevier BV
Published
2021-01
Volume
160
Issue
1
Pages
227-233
ISSN
0090-8258 (ISSN-L)
OpenAlex
W3099006076
Cited by
15
References
39
Citations by year
2026: 4 · 2025: 3 · 2024: 3 · 2023: 2 · 2022: 3
FWCI
0.45
Type
journal article
Language
en
Open access
closed
Locations
  • Gynecologic Oncology (publishedVersion)
  • PubMed (publishedVersion)
  • Radboud Repository (Radboud University) (submittedVersion)
Funders
Dana-Farber Cancer Institute
Topics
  • Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy
  • Health Sciences › Medicine › Oncology › Cancer survivorship and care
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian cancer diagnosis and treatment
Keywords
treatment-related fatigue, PARP inhibitors, advanced ovarian cancer, oral maintenance therapy, patient lived experience, social support, treatment discontinuation, social isolation, quality of life
MeSH terms
Poly(ADP-ribose) Polymerase Inhibitors, Aged, Aged, 80 and over, Fatigue, Female, Humans, Middle Aged, Ovarian Neoplasms, Quality of Life, Qualitative Research

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review